VNQI vs XBI
Vanguard Global ex-US Real Estate ETF vs SPDR S&P Biotech ETF
- • VNQI has the lower expense ratio at 0.12% vs 0.35% for XBI.
- • VNQI pays a higher dividend yield (4.81%).
Side-by-side metrics
| Metric | VNQI | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.12% | 0.35% |
Dividend yield Trailing 12-month yield. | 4.81% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $3.71B | $10.73B |
YTD return | -1.66% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.95 | 1.10 |
P/E ratio | 12.55 | — |
Last price | $45.22 | $164.01 |
Inception | — | — |
Issuer | Vanguard | State Street |
VNQI top holdings
| GMG.AX | Goodman Group | 4.28% |
| 8802.T | Mitsubishi Estate Co Ltd | 2.83% |
| 8801.T | Mitsui Fudosan Co Ltd | 2.45% |
| 0016.HK | Sun Hung Kai Properties Ltd | 2.37% |
| 8830.T | Sumitomo Realty & Development Co Ltd | 2.01% |
| VNA.DE | Vonovia SE | 1.93% |
| EMAAR.AE | Emaar Properties PJSC | 1.84% |
| 1925.T | Daiwa House Industry Co Ltd | 1.52% |
| SCG.AX | Scentre Group | 1.32% |
| URW.PA | Unibail-Rodamco-Westfield Act. SIIC ET STES FONC.EUROP. | 1.30% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About VNQI
VNQI (Vanguard Global ex-US Real Estate ETF) is Non-US REITs and real estate companies globally. Managed by Vanguard, the fund carries $3.7B in assets under management, an expense ratio of 0.12%, a dividend yield of 4.81%. Its largest holding is Goodman Group (GMG.AX), which represents 4.3% of the portfolio. Real Estate is the fund's largest sector exposure at 98.5%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.